HitchcockCL, BlandKI, LaneyRGIII et al.. Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis, and treatment. Ann Surg1988;207:201–207.
HitchcockCLBlandKILaneyRGIII. Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis, and treatment. Ann Surg 1988;207:201–207.
)| false
SkeltonHG, SmithKJ, HitchcockCL et al.. Merkel cell carcinoma: analysis of clinical, histologic, and immunohistologic features of 132 cases with relation to survival. J Am Acad Dermatol1997;37:734–739.
SkeltonHGSmithKJHitchcockCL. Merkel cell carcinoma: analysis of clinical, histologic, and immunohistologic features of 132 cases with relation to survival. J Am Acad Dermatol 1997;37:734–739.
)| false
Medina-FrancoH, UristMM, FiveashJ et al.. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann Surg Oncol2001;8:204–208.
Medina-FrancoHUristMMFiveashJ. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann Surg Oncol 2001;8:204–208.
)| false
GillenwaterAM, HesselAC, MorrisonWH et al.. Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg2001;127:149–154.
GillenwaterAMHesselACMorrisonWH. Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg 2001;127:149–154.
)| false
AllenPJ, BowneWB, JaquesDP et al.. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol2005;23:2300–2309.
AllenPJBowneWBJaquesDP. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 2005;23:2300–2309.
)| false
CheukW, KwanMY, SusterS, ChanJK. Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas. Arch Pathol Lab Med2001;125:228–231.
CheukWKwanMYSusterSChanJK. Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas. Arch Pathol Lab Med 2001;125:228–231.
)| false
HanlyAJ, ElgartGW, JordaM et al.. Analysis of thyroid transcription factor-1 and cytokeratin 20 separates merkel cell carcinoma from small cell carcinoma of lung. J Cutan Pathol2000;27:118–120.
HanlyAJElgartGWJordaM. Analysis of thyroid transcription factor-1 and cytokeratin 20 separates merkel cell carcinoma from small cell carcinoma of lung. J Cutan Pathol 2000;27:118–120.
)| false
SchmalbachCE, LoweL, TeknosTN et al.. Reliability of sentinel lymph node biopsy for regional staging of head and neck Merkel cell carcinoma. Arch Otolaryngol Head Neck Surg2005;131:610–614.
SchmalbachCELoweLTeknosTN. Reliability of sentinel lymph node biopsy for regional staging of head and neck Merkel cell carcinoma. Arch Otolaryngol Head Neck Surg 2005;131:610–614.
)| false
SuLD, LoweL, BradfordCR et al.. Immunostaining for cytokeratin 20 improves detection of micrometastatic Merkel cell carcinoma in sentinel lymph nodes. J Am Acad Dermatol2002;46:661–666.
SuLDLoweLBradfordCR. Immunostaining for cytokeratin 20 improves detection of micrometastatic Merkel cell carcinoma in sentinel lymph nodes. J Am Acad Dermatol 2002;46:661–666.
)| false
O’ConnorWJ, RoenigkRK, BrodlandDG. Merkel cell carcinoma. Comparison of Mohs micrographic surgery and wide excision in eighty-six patients. Dermatol Surg1997;23:929–933.
O’ConnorWJRoenigkRKBrodlandDG. Merkel cell carcinoma. Comparison of Mohs micrographic surgery and wide excision in eighty-six patients. Dermatol Surg 1997;23:929–933.
)| false
GuptaSG, WangLC, PenasPF et al.. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature. Arch Dermatol2006;142:685–690.
GuptaSGWangLCPenasPF. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature. Arch Dermatol 2006;142:685–690.
)| false
AmesSE, KragDN, BradyMS. Radiolocalization of the sentinel lymph node in Merkel cell carcinoma: a clinical analysis of seven cases. J Surg Oncol1998;67:251–254.
AmesSEKragDNBradyMS. Radiolocalization of the sentinel lymph node in Merkel cell carcinoma: a clinical analysis of seven cases. J Surg Oncol 1998;67:251–254.
)| false
MehranyK, OtleyCC, WeenigRH et al.. A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma. Dermatol Surg2002;28:113–117; discussion 117.
MehranyKOtleyCCWeenigRH. A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma. Dermatol Surg 2002;28:113–117; discussion 117.
)| false
MessinaJL, ReintgenDS, CruseCW et al.. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol1997;4:389–395.
MessinaJLReintgenDSCruseCW. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol 1997;4:389–395.
)| false
JabbourJ, CummingR, ScolyerRA et al.. Merkel cell carcinoma: assessing the effect of wide local excision, lymph node dissection, and radiotherapy on recurrence and survival in early-stage disease—results from a review of 82 consecutive cases diagnosed between 1992 and 2004. Ann Surg Oncol2007;14:1943–1952.
JabbourJCummingRScolyerRA. Merkel cell carcinoma: assessing the effect of wide local excision, lymph node dissection, and radiotherapy on recurrence and survival in early-stage disease—results from a review of 82 consecutive cases diagnosed between 1992 and 2004. Ann Surg Oncol 2007;14:1943–1952.
)| false
GarneskiKM, NghiemP. Merkel cell carcinoma adjuvant therapy: current data support radiation but not chemotherapy. J Am Acad Dermatol2007;57:166–169.
GarneskiKMNghiemP. Merkel cell carcinoma adjuvant therapy: current data support radiation but not chemotherapy. J Am Acad Dermatol 2007;57:166–169.
)| false
PoulsenM, RischinD, WalpoleE et al.. High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study—TROG 96:07. J Clin Oncol2003;21:4371–4376.
PoulsenMRischinDWalpoleE. High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study—TROG 96:07. J Clin Oncol 2003;21:4371–4376.
)| false
PoulsenMG, RischinD, PorterI et al.. Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin?Int J Radiat Oncol Biol Phys2006;64:114–119.
PoulsenMGRischinDPorterI. Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin?Int J Radiat Oncol Biol Phys 2006;64:114–119.
)| false
TaiPT, YuE, WinquistE et al.. Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases. J Clin Oncol2000;18:2493–2499.
TaiPTYuEWinquistE. Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases. J Clin Oncol 2000;18:2493–2499.
)| false
